Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 1068-1080

  Sun, Zhe ^a   Xu, Ying Ying ^a   Wang, Zhen Ning ^a   Zhu, Zhi ^a   Zhang, Hao ^a   Huang, Bao Jun ^a   Xu, Yan ^a   Chen, Jun Qing ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROSCOPIC SEROSAL CLASSIFICATION; MAJOR CLINICAL STUDY; MALE; PERITONEUM CANCER; STOMACH CANCER;

FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROUS MEMBRANE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 79955812237     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1449-6     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96. (Pubitemid 351521864)
2. Goggins WB, Wong GK. Poor survival for US Pacific Islander cancer patients: evidence from the Surveillance, Epidemiology, and End Results database: 1991 to 2004. J Clin Oncol. 2007; 25:5738-41.
3. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808-16. (Pubitemid 39425773)
4. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113-9. (Pubitemid 37152170)
5. Benevolo M, Mottolese M, Cosimelli M, Tedesco M, Giannarelli D, Vasselli S, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol. 1998;16: 3406-11. (Pubitemid 28481640)
6. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996;83:672-4. (Pubitemid 26163552)
7. Abe S, Yoshimura H, Tabata H, Tachibana M, Monden N, Nakamura T, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol. 1995;59:226-9.
8. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg. 2002;235: 499-506. (Pubitemid 34258348)
9. Nakanishi H, Kodera Y, Yamamura Y, Ito S, Kato T, Ezaki T, et al. Rapid quantitative detection of carcinoembryonic antigenexpressing free tumor cells in the peritoneal cavity of gastric cancer patients with real-time RT-PCR on the lightcycler. Int J Cancer. 2000;89:411-7.
10. Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer. 2005;93:986-92. (Pubitemid 41548391)
11. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K. Prognostic factors in gastric cancer with serosal invasion: univariate and multivariate analyses. Arch Surg. 1989;124:1061-4. (Pubitemid 19231244)
12. Sobin L, Gospodarowicz M, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. International Union Against Cancer (UICC). New York: Wiley, 2009.
13. Ichiyoshi Y, Maehara Y, Tomisaki S, Oiwa H, Sakaguchi Y, Ohno S, et al. Macroscopic intraoperative diagnosis of serosal invasion and clinical outcome of gastric cancer: risk of underestimation. J Surg Oncol. 1995;59:255-60.
14. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol. 1999;72:60-4 (discussion 64-5).
15. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer. 1998;1:10-24.
16. Homma Y, Ushida S, Yamada M, Kobayashi H, Suzuki K. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients. Ann Surg Oncol. 2010;17:455-60.
17. Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg. 2002;26:1160-5. (Pubitemid 36920276)
18. Soga K, Ichikawa D, Yasukawa S, Kubota T, Kikuchi S, Fujiwara H, et al. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer. Surgery. 2010;147: 197-203.
19. Bando E, Kawamura T, Kinoshita K, Takahashi S, Maeda A, Osada S et al. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer. J Am Coll Surg. 2003;197:212-22. (Pubitemid 36927384)
20. Abe S, Shiraishi M, Nagaoka S, Yoshimura H, Dhar DK, Nakamura T. Serosal invasion as the single prognostic indicator in stage III A (T3N1M0) gastric cancer. Surgery. 1991;6:582-8.
21. Baba H, Korenaga D, Haraguchi M, Okamura T, Saito A, Watanabe A, et al. Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion. Cancer. 1989;15:2482-6. (Pubitemid 20014929)
22. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85:529-34. (Pubitemid 29075274)
23. Rosen HR, Jatzko G, Repse S, Potrc S, Neudorfer H, Sandbichler P, et al. Adjuvant intraperitoneal chemotherapy with carbonadsorbed mitomycin in patients with gastric cancer: results of a randomised multi-center trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol. 1998;16:2733-8. (Pubitemid 28363038)
24. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21: 3737-43. (Pubitemid 46606227)
25. Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:1330-6.
26. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702-13. (Pubitemid 47460649)
27. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multiinstitutional experience. J Clin Oncol. 2009;27:6237-42.
28. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg. 1993;217:356-68. (Pubitemid 23115339)
29. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144-53.
30. Elias D, Goere D, Blot F, Billard V, Pocard M, Kohneh-Shahri N, et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol. 2007;14:1818-24. (Pubitemid 46870938)
31. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24:4011-9. (Pubitemid 46630752)
32. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900-7.